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Abstract 
We report an extremely rare case of malig-
nant Triton tumor developing in the retroperi-
toneal space in a patient with neurofibromato-
sis type 1. A 21-year old man who had been
diagnosed with neurofibromatosis type 1 was
admitted to our hospital with the chief com-
plaint of a palpable abdominal mass. Abdominal
computed tomography revealed a huge hetero-
geneous  tumor  measuring  approximately  17
cm  in  diameter  occupying  the  left  retroperi-
toneal space, and numerous metastatic lesions
between the left psoas muscle and the left thigh
with dissolution of the left hip joint. After the
diagnosis of a retroperitoneal malignant neuro-
genic tumor, resection of the tumor with recon-
struction of the abdominal aorta was conduct-
ed, followed by postoperative transarterial infu-
sion chemotherapy. The histopathological diag-
nosis was malignant peripheral nerve sheath
tumor with rhabdomyosarcomatous differentia-
tion,  namely  malignant  Triton  tumor.
Postoperative chemo-therapy was in vain and
the patient died 14 months after the surgery as
a result of lung metastasis.  
Introduction
Malignant Triton tumor (MTT) is a histolog-
ical  variant  of  malignant  peripheral  nerve
sheath tumors (MPNSTs) with rhabdomyosar-
comatous  differentiation.  Although  MPNSTs
have been known to develop in cases of neu-
rofibromatosis  type  1  (von  Recklinghausen’s
disease, NF-1) and sometimes to occur in the
retroperitoneal space, there are few reports of
MTTs developing in the retroperitoneal space.
We report an extremely rare case of MTT devel-
oping in the retroperitoneal space in a patient
with NF-1 and describe the clinicopathological
features of this tumor. 
Case Report 
A 21-year old man, who had been diagnosed
to have NF-1 by a dermatologist when he was
about a year old, was referred to Fujita Health
University  Hospital  in  November  2004,
because of a left lower abdominal mass and
gradually increasing pain in the same region.
Physical examination revealed many café-au-
lait spots,  subcutaneous  masses  of  various
sizes, scoliosis, and a firm fixed mass in the
left lower abdomen the size of a baby’s head.
The left lower extremity was markedly swollen
and  the  patient  had  difficulty  in  walking.
Laboratory  examination  revealed  slight  ane-
mia and elevated serum CRP; however, other
serum chemistry data were within normal lim-
its. Abdominal computed tomography revealed
a huge heterogeneous tumor approximately 17
cm in diameter occupying the left retroperi-
toneal  space  (Figure  1).  Numerous  other
tumors,  which  seemed  to  be  metastatic
lesions,  were  found  between  the  left  psoas
muscle and the left thigh with dissolution of
the left hip joint (Figure 2). On magnetic reso-
nance imaging, the tumor was visualized as a
low  intensity  signal  on  T1-weighted  images
and as a high intensity signal on T2-weighted
images.  
After the diagnosis of retroperitoneal malig-
nant neurogenic tumor associated with NF-1, a
laparotomy  was  performed.  A  giant,  firm,
whitish,  well-capsulated  tumor  was  found
occupying  the  left  abdomen  (Figure  3).
Although the main tumor appeared to be tight-
ly adherent to the psoas muscle and to involve
the abdominal aorta, there was no gross inva-
sion of other adjacent organs. Resection of the
main  tumor  and  of  the  nodules  in  the
retroperitoneal space that were suspected to
be metastatic lesions and reconstruction of the
abdominal aorta were conducted. 
Macroscopically, the extirpated main tumor
measured 19x15x13 cm in size and was encap-
sulated. The cut surface of the tumor revealed
solid  and  yellowish  tissue  in  the  peripheral
portion and foci of hemorrhage and necrosis in
the  central  portion  of  the  tumor.  Histo-
pathological  examination  revealed  spindle-
shaped  cells  with  wavy  nuclei  and  slightly
eosinophilic cytoplasm, showing dense prolif-
eration and forming storiform structures, with
a  myxomatous  stroma  (Figure  4A).  On
immunostaining,  the  spindle-shaped  tumor
cells showed a positive response for S-100 pro-
tein  and  NSE,  with  sporadic  distribution  of
rhabdomyoblastic  cells  that  showed  positive
staining  for  myoglobin  and  desmin  (Figure
4B).  Immunohistochemical  staining  with  S-
100 and desmin indicated that the tumor cells
originated  from  Schwann  cells  and  showed
rhabdomyosarcomatous differentiation. Based
on these findings, a diagnosis of MTT associat-
ed with MPNST was made. 
After surgical treatment, transarterial infu-
sion chemotherapy was administered via the
left  common  iliac  artery  for  the  remnant
tumors in the left hip joint and the left thigh,
and the patient was discharged five months
after the surgery. However, eight months after
being discharged, the patient was readmitted
for dyspnea found to be caused by lung metas-
tasis. Despite administration of transarterial
chemotherapy, the tumors increased greatly in
size, and the patient died 14 months after the
surgery. An autopsy was not performed. 
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Figure 1. Abdominal computed tomography showing a huge tumor occupying the left
retroperitoneal space and a metastatic mass in the left psoas muscle (arrows). [Rare Tumors 2009; 1:e27] [page 83]
Discussion 
NF-1  is  an  autosomal  dominant  disorder
characterized by café-au-lait spots, cutaneous
neurofibromas, skeletal dysplasias, Lisch nod-
ules, and sometimes malignant tumors, and it
occurs with an incidence of approximately one
in 3000 live births.
1 MPNSTs are well known to
arise from major and minor peripheral nerves
or  within  pre-existing  neurofibromas,  and
approximately  50  percent  of  patients  with
MPNSTs  have  NF-1.
2,3 The  World  Health
Organization coined the term MPNST in place
of the previously used, often confusing, termi-
nology  such  as  “malignant  schwannoma,”
“malignant neurilemmoma,” “neurogenic sar-
coma,” and “neurofibrosarcoma.”
4 The precise
cell of origin of MPNSTs has not yet been con-
clusively identified, although the Schwann cell
is thought to be the major candidate cell for
this.  The  overall  five-year  survival  rate  in
patients with MPNSTs has been reported to be
34-44%, and the association of these tumors
with NF-1 is predictive of a poor prognosis.
2,3
The  capacity  of  MPNSTs  to  undergo  focal
divergent  differentiation  is  well  known,  and
tumors  showing  rhabdomyosarcomatous  dif-
ferentiation, referred to as MTTs, are identi-
fied in approximately 12 percent of patients
with MPNSTs.
2
Woodruff et al. (1973) reported a series of
10 cases of malignant schwannoma with rhab-
domyoblastic differentiation, which they were
the  first  to  refer  to  as  MTTs.
5 Immunohi-
stochemical staining for skeletal muscle mark-
ers such as myoglobin or desmin is essential
for making a correct diagnosis of MTT, because
of the histological variations of MPNSTs. The
average  age  of  patients  with  MTTs  is  31.7
years  and  these  tumors  occur  with  approxi-
mately equal frequency in males and females.
6
The reported incidence of MTTs occurring in
association with NF-1 is in the range of 44-69.
Several authors have reported that MTTs are
associated  with  a  worse  prognosis  than
MPNSTs, regardless of whether or not they are
associated with NF-1,
7,8 with a five-year sur-
vival rate of 12-26%.
6,7
The reason for the more aggressive behav-
ior of MTTs than classic MPNSTs still remains
unclear.  MTTs  occur  predominantly  in  the
trunk, head and neck, and lower extremities.
8
According to a review of 75 cases of MTTs by
Yakulis et al. (1996), the tumor was located in
the retroperitoneum in only one case (1.3%).
6
Subsequent to the publication of this review,
we could identify only one case of retroperi-
toneal MTT by a PubMed search of the English
language literature using the terms “retroperi-
toneum” or “retroperitoneal” and “Triton.”
9 All
the  three  cases  of  MTTs  developing  in  the
retroperitoneal space reported so far, including
the  present  case,  presented  with  a  huge
abdominal mass,
6,9 since these retroperitoneal
tumors are often asymptomatic in the earlier
stages. 
Like most soft-tissue sarcomas, MTTs tradi-
tionally are insensitive to chemotherapy and
radiotherapy.  However,  several  authors  have
reported recently that repeated resection com-
bined with chemotherapy and/or radiotherapy
against recurrent MTTs might prolong the sur-
vival  in  patients  with  MTTs.
10,11 Because
MPNSTs  and  MTTs  have  a  high  malignant
potential,  patients  with  NF-1  should  be  fol-
lowed by periodic check-ups, including com-
puted tomography for early detection of such
tumors as these, and multidisciplinary treat-
ments  including  complete  resection  are
required for patients with MTTs. 
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